- Uracil
- UraciL mixture with Tegafur (4:1)
- Uracil, 1-(3-azido-3-deoxy-b-D-arabinofuranosyl)-
- Uracil, 1-b-D-xylofuranosyl-,5'-methanesulfonate (7CI,8CI)
- Uracil, 3-b-D-ribofuranosyl-,2',3',5'-triacetate (8CI)
- Uracil,6,6'-[(1,3-dimethylpropanediylidene)dinitrilo]bis[5-amino-1,3-dimethyl- (8CI)
- URACIL-5-3H
- Uracil-5-carboxylic acid
- 745784-04-72-Pyridinecarboxylicacid, 3,5-difluoro-
- 745784-12-7Boronic acid,B-2-quinolinyl-
- 74578-69-15-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-,sodium salt (1:2), (6R,7R)-
- 745833-17-4N-Boc-2,6-difluoroaniline
- 745833-19-63-Pyridinecarboxylicacid, 6-chloro-2-(2,4-difluorophenyl)-, ethyl ester
- 74583-53-21,4 SUPHO PHENOL 3 METHYL 5 PYRAZOLONE
- 745836-21-9ANTI-2-AZABICYCLO[2.2.1]HEPTANE-7-CARBOXYLIC ACID ETHYL ESTER
- 745836-28-62-Azabicyclo[2.2.1]heptane,7-chloro-2-(phenylmethyl)-, (1R,4R,7R)-rel-
- 745836-30-02-Azabicyclo[2.2.1]heptane-7-carbonitrile,2-(phenylmethyl)-, (1R,4S,7R)-rel-
- 74586-53-1Benzenamine,3-bromo-5-methyl-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
UraciL mixture with Tegafur (4:1) |
EINECS | N/A |
| CAS No. | 74578-38-4 | Density | N/A |
| PSA | 130.59000 | LogP | 0.28480 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C12H13FN4O5 | Boiling Point | 467.1 °C at 760 mmHg |
| Molecular Weight | 648.59 | Flash Point | 236.3 °C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
FT mixt. with uracil (1:4);Uracil mixt. with 1-(2-tetrahydrofuryl)-5-fluorouracil (4:1);2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, mixt. with 2,4(1H,3H)-pyrimidinedione;1-UFT protocol;Youfuding;Tegafur mixt. with uracil (1:4);5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione; 1H-pyrimidine-2,4-dione;Tegafur - uracil mixture;UFT;1-(2-Tetrahydrofuryl)-5-fluorouracil mixt. with uracil (1:4);Uracil, 5-fluoro-1-(tetrahydro-2-furyl)- mixt. with uracil (1:4);Ufur;Uracil-Tegafur;Uracil mixt. with FT (4:1);2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-(tetrahydro- 2-furanyl)-,mixt. with 2,4(1H,3H)-pyrimidinedione;TEGAFUR mixture with URACIL (1:4);URACIL mixture with 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL (4:1);1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL mixture with URACIL (1:4);FT mixture with URACIL (1:4);URACIL mixture with FT (4:1);Uracil mixt. with tegafur (4:1); |
UraciL mixture with Tegafur (4:1) Specification
The UraciL mixture with Tegafur (4:1), with the CAS registry number 74578-38-4, is also known as Uracil, 5-fluoro-1-(tetrahydro-2-furyl)- mixt. with uracil (1:4). This chemical's molecular formula is C12H13FN4O5 and molecular weight is 312.253823. Its IUPAC name is called 5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione; 1H-pyrimidine-2,4-dione. This chemical's classification codes are Antineoplastic Agents; Drug / Therapeutic Agent; Reproductive Effect.
Physical properties of UraciL mixture with Tegafur (4:1): (1)ACD/LogP: -0.77; (2)ACD/LogD (pH 5.5): -0.77; (3)ACD/LogD (pH 7.4): -0.81; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 9.03; (7)ACD/KOC (pH 7.4): 8.23; (8)#H bond acceptors: 5; (9)#H bond donors: 1; (10)#Freely Rotating Bonds: 1; (11)Flash Point: 236.3 °C; (12)Enthalpy of Vaporization: 72.9 kJ/mol; (13)Boiling Point: 467.1 °C at 760 mmHg; (14)Vapour Pressure: 6.72E-09 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)Canonical SMILES: C1CC(OC1)N2C=C(C(=O)NC2=O)F.C1=CNC(=O)NC1=O
(2)InChI: InChI=1S/C8H9FN2O3.C4H4N2O2/c9-5-4-11(6-2-1-3-14-6)8(13)10-7(5)12;7-3-1-2-5-4(8)6-3/h4,6H,1-3H2,(H,10,12,13);1-2H,(H2,5,6,7,8)
(3)InChIKey: DHMYGZIEILLVNR-UHFFFAOYSA-N
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LD50 | oral | 150mg/kg (150mg/kg) | BEHAVIORAL: TREMOR VASCULAR: OTHER CHANGES GASTROINTESTINAL: NAUSEA OR VOMITING | Oyo Yakuri. Pharmacometrics. Vol. 20, Pg. 1009, 1980. |
| mouse | LD50 | oral | 1275mg/kg (1275mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA BLOOD: OTHER CHANGES | Oyo Yakuri. Pharmacometrics. Vol. 20, Pg. 1009, 1980. |
| rabbit | LD50 | oral | 242mg/kg (242mg/kg) | VASCULAR: OTHER CHANGES | Oyo Yakuri. Pharmacometrics. Vol. 20, Pg. 1009, 1980. |
| rat | LD50 | oral | 1580mg/kg (1580mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA BLOOD: OTHER CHANGES | Oyo Yakuri. Pharmacometrics. Vol. 20, Pg. 1009, 1980. |
What can I do for you?
Get Best Price
